Billing Code: 4163-18-P

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

National Organizations Working to Eliminate Perinatal HIV Transmission and to Implement CDC’s Revised Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in U.S. Health Care Settings

Announcement Type: New

Funding Opportunity Number: CDC- RFA-PS07-764

Catalog of Federal Domestic Assistance Number: 93.941

Key Dates:

Application Deadline: July 27, 2007

I. Funding Opportunity Description

Authority: This program is authorized under section 301(a) and 318 of the Public Health Service Act, (42 U.S.C. section 241(a) and 24c) as amended.

Purpose: The purpose of the program is to: (1) develop, provide and disseminate technical assistance, administrative tools and other educational and training materials needed to improve perinatal HIV prevention efforts nationally; (2) develop, provide and disseminate technical assistance, administrative tools and other educational and training materials needed to implement HHS/CDC’s Revised Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in Health Care Settings; and (3) foster the exchange of information, ideas and experiences of routine HIV testing in health care settings by assessing attitudes, reactions and acceptance of HIV screening by health care providers and patients. This program addresses the “Healthy People 2010” focus areas of HIV and Maternal, Infant and Child Health.

Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP): (1) reduce the number of new HIV infections; (2) increase the number of HIV-infected people who know they are infected; and (3) increase the proportion of HIV-infected people who are linked to appropriate prevention, care and treatment services.

This announcement includes three components. Applicants may submit applications with any one, two or all three components. The application should make clear which components are being addressed.

This announcement is only for non-research activities supported by HHS/CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the HHS/CDC Web site at the following Internet address: http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm.

Activities- Component 1: Perinatal HIV Transmission Prevention

Awardee activities for this program component are as follows:

· Provide education and technical assistance to hospitals and health care providers in sharing and applying knowledge and expertise regarding the prevention of perinatal HIV transmission in the United States. Specifically, develop and disseminate educational materials, administrative tools, evaluation methods and provide training and technical assistance on approaches to help providers: (1) achieve high rates of HIV screening among pregnant women in health care settings by using HHS/CDC-recommended practices, including opt-out screening; (2) provide appropriate antiretroviral prophylaxis to HIV-infected pregnant women; (3) provide recommended pre-conception and inter-conception care for HIV-infected women; and (4) and linking HIV-infected women and their HIV-exposed infants to comprehensive medical and social services.

· Sponsor a variety of forums or workshops for presentation of information on HIV testing of adults, adolescents and pregnant women in health care settings and on the reduction of perinatal HIV transmission (i.e., policies, programs, materials and other technical information) among health care providers.

· Collaborate with other funded national organizations and HHS/CDC, Division of HIV/AIDS Prevention and other Centers, Institutes and Offices (CIOs) within HHS/CDC and operating divisions within HHS that support HIV prevention and treatment to assess needs and provide technical assistance.

· Participate in HHS/CDC-sponsored meeting(s) and conference calls on HIV testing in health care settings and/or on perinatal HIV prevention in the United States.

In a cooperative agreement, HHS/CDC staff are substantially involved in the program activities, above and beyond routine grant monitoring.

HHS/CDC activities for this program are as follows:

· Facilitate and assist in the development of training materials and curricula, administrative tools and policy manuals.

· Work with each awardee to facilitate and support collaboration among funded national organizations, health departments, and as well as HHS/CDC-funded HIV prevention and surveillance programs.

· Collaborate in the development of forums that focus on HIV testing of adults, adolescents and pregnant women in health care settings and also other public health information that relates to prevention of perinatal HIV transmission.

· Assist in the evaluation of education, training and materials.

· Collaborate in the presentation and publication of evaluation findings.

· Conduct site visits to monitor progress of the programs.

Funding preference will be given to national organizations that can demonstrate prior experience providing training to health care providers regarding: (1) incorporation of PMTCT into health care provider education; (2) offering of universal voluntary HIV testing to pregnant women as a routine part of prenatal care; (3) implementation of voluntary rapid HIV testing programs in labor and delivery settings; and (4) national organizations that have developed and disseminated patient educational materials on HIV, perinatal HIV and its prevention.

Activities Component 2: HIV Screening

Awardee activities for this program component are as follows:

· Provide education and technical assistance to hospitals and health care providers in initiating HIV screening, and sharing and applying knowledge and expertise regarding HIV screening and diagnosis. Specifically, awardees will develop and disseminate educational materials, and administrative tools, and provide training and technical assistance to help providers achieve high rates of HIV screening among adults, adolescents and pregnant women in health care settings by using HHS/CDC-recommended practices, including opt-out screening, and linking HIV-infected persons to comprehensive medical and social services. The intended health care settings include: hospitals (emergency departments, urgent care clinics and inpatient services), primary care settings (community health centers, general medicine clinics, adolescent medicine/pediatric and family planning/gynecology clinics), substance abuse treatment clinics and sexually transmitted disease clinics.

· Participate in HHS/CDC-sponsored meeting(s) and conference calls on HIV testing in health care settings in the United States.

In a cooperative agreement, HHS/CDC staff are substantially involved in the program activities, above and beyond routine grant monitoring.

HHS/CDC activities for this program are as follows:

· Facilitate and assist in the development of training materials and curricula, administrative tools and policy manuals.

· Work with each awardee to facilitate and support collaboration among funded national organizations, health departments, and HHS/CDC-funded HIV prevention and surveillance programs.

· Collaborate in the development of forums that focus on HIV testing of adults, adolescents and pregnant women in health care settings.

· Assist in the evaluation of education, training and materials.

· Collaborate in the presentation and publication of evaluation findings.

· Conduct site visits to monitor progress of the programs.

Funding preference will be given to national organizations that can demonstrate prior experience providing training to health care providers, and those that have developed, evaluated, and disseminated educational materials, such as pre-test informational pamphlets, that are suitable for use as part of HIV screening programs in health care settings.

Activities Component 3: Evaluation

Awardee activities for this program component are as follows:

· Provide technical assistance to hospitals and health care providers through the development, design, and dissemination of effective evaluation models for determining the effect that expanded HIV screening activities have on patient attitudes toward and acceptance of HIV testing. Specifically, awardees will develop and disseminate educational materials, administrative tools, and evaluation methods, and provide training and technical assistance on their use to assess patient outcomes, satisfaction, and attitudes with respect to HHS/CDC-recommended practices, including opt-out screening, patients’ perceptions of their ability to decline testing, the sufficiency and effectiveness of methods used to impart information prior to testing, and the acceptability of different methods for providing test results. The intended health care settings for which evaluation methods should be developed include: hospitals (emergency departments, urgent care clinics, inpatient services and labor and delivery), primary care settings (prenatal care clinics, community health centers, and adolescent medicine clinics), and sexually transmitted disease clinics.

· Participate in HHS/CDC-sponsored meeting(s) and conference calls on HIV testing in health care settings in the United States.

Although awardees may participate in the implementation of evaluation methods at a limited number of specific sites for the purpose of development, field testing, and process improvement, the primary objective of this component is to develop tools suitable for independent use by the individual health-care settings for evaluating their own programs.

In a cooperative agreement, HHS/CDC staff are substantially involved in the program activities, above and beyond routine grant monitoring.

HHS/CDC activities for this program are as follows:

· Facilitate and assist in the development of training materials and curricula, administrative tools and policy manuals.

· Work with each awardee to facilitate and support collaboration among funded national organizations, health departments, and as well as HHS/CDC-funded HIV prevention and surveillance programs.

· Collaborate in the development of relevant topics and questions for evaluation.

· Assist in the assessments of evaluation methods.

· Collaborate in the presentation and publication of evaluation findings.

· Conduct site visits to monitor progress of the programs.

Funding preference will be given to national organizations that can demonstrate at least two years’ prior experience in developing and disseminating evaluation methods for health care providers, and those with specific experience related to evaluation of provider behavior and patient outcomes related to screening, identification of management of HIV infection.

II. Award Information

Component 1: Perinatal HIV Transmission Prevention

Type of Award: Cooperative Agreement

CDC’s involvement in this program is listed in the Activities Section above.

Award Mechanism: U65 - Minority/Other Community-Based Human Immunodeficiency Virus (HIV) Prevention Projects--Cooperative Agreements

Fiscal Year Funds: 2007

Approximate Current Fiscal Year Funding: $740,000

Approximate Total Project Period Funding: $ 3,700,000 (This amount is an estimate, and is subject to availability of funds.) This amount includes both direct and indirect costs.

Approximate Number of Awards: 3-6

Approximate Average Award: $ 175,000 (This amount is for the first 12-month budget period, and includes both direct and indirect costs.)

Floor of Individual Award Range: None

Ceiling of Individual Award Range: $300,000 (This ceiling is for the first 12-month budget period.)

Anticipated Award Date: August 31, 2007

Budget Period Length: 12 months

Project Period Length: 5 years

Component 2: HIV Sreening

Type of Award: Cooperative Agreement

CDC’s involvement in this program is listed in the Activities Section above.

Award Mechanism: U65 - Minority/Other Community-Based Human Immunodeficiency Virus (HIV) Prevention Projects--Cooperative Agreements

Fiscal Year Funds: 2007

Approximate Current Fiscal Year Funding: $700,000

Approximate Total Project Period Funding: $ 700,000- $1,400,000 (This amount is an estimate, and is subject to availability of funds.) This amount includes both direct and indirect costs.

Approximate Number of Awards: 3-6

Approximate Average Award: $ 175,000 (This amount is for the first 12-month budget period, and includes both direct and indirect costs.)

Floor of Individual Award Range: None

Ceiling of Individual Award Range: $300,000 (This ceiling is for the first 12-month budget period.)

Anticipated Award Date: August 31, 2007

Budget Period Length: 12 months

Project Period Length: 1-2 years, possibly up to 5 years

Component 3: Evaluation

Type of Award: Cooperative Agreement

CDC’s involvement in this program is listed in the Activities Section above.

Award Mechanism: U65 - Minority/Other Community-Based Human Immunodeficiency Virus (HIV) Prevention Projects--Cooperative Agreements

Fiscal Year Funds: 2007

Approximate Current Fiscal Year Funding: $300,000

Approximate Total Project Period Funding: $ 300,000-$600,000 (This amount is an estimate, and is subject to availability of funds.) This amount includes both direct and indirect costs.

Approximate Number of Awards: 1

Approximate Average Award: $ 300,000 (This amount is for the first 12-month budget period, and includes both direct and indirect costs.)

Floor of Individual Award Range: None

Ceiling of Individual Award Range: $300,000 (This ceiling is for the first 12-month budget period.)

Anticipated Award Date: August 31, 2007

Budget Period Length: 12 months

Project Period Length: 1-2 years, possibly up to 5 years

Throughout the project period, HHS/CDC’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government. It is anticipated that the Screening and Evaluation components will receive funding for at least one year, and possibly two to five years, depending on funds availability. Applicants should project and budget their proposals accordingly.

III. Eligibility Information

III.1. Eligible Applicants

Applications may be submitted by organizations having demonstrated experience providing needs assessments, capacity building, curricula and training in health care settings and with health care providers, including: pediatricians, obstetricians, family practitioners, nurses, nurse-midwives, nurse practitioners, health educators, emergency medicine physicians, internal medicine physicians, infectious disease clinicians and other health care providers. Eligible applicants that can apply for this funding opportunity are listed below:

· Public nonprofit organizations

· Private nonprofit organizations

· For profit organizations

· Small, minority, and women-owned businesses

· Universities

· Colleges

· Research institutions

· Hospitals

· Community-based organizations

· Faith-based organizations

· Federally recognized Indian tribal governments

· Indian tribes

· Indian tribal organizations

· State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).

For components 1 and 2, funding preference will be given to organizations that have the capability to serve the broadest U.S. health care audiences by supporting national efforts to assure consistent messages in training and education.

For component 1, funding preference will be given to organizations with two years of prior experience providing nation-wide training to health care providers regarding: (1) incorporation of PMTCT into health care provider education; (2) offering of universal voluntary HIV testing to pregnant women as a routine part of prenatal care; (3) implementation of voluntary rapid HIV testing programs in labor and delivery settings; and (4) the development and dissemination of patient educational materials on HIV, perinatal HIV and its prevention on a national scope.

III.2. Cost Sharing or Matching

Matching funds are not required for this program.

III.3. Other

HHS/CDC will accept and review applications with budgets greater than the ceiling of the award range.

Special Requirements:

If the application is incomplete or non-responsive to the special requirements listed in this section, it will not be entered into the review process. The applicant will be notified the application did not meet submission requirements.

· Late applications will be considered non-responsive. See section “IV.3. Submission Dates and Times” for more information on deadlines.

· Awardees will be required to cooperate with other awardees and HHS/CDC to develop comprehensive and complementary projects.

· Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

IV. Application and Submission Information

IV.1. Address to Request Application Package

To apply for this funding opportunity use application form PHS 5161-1.

Electronic Submission:

HHS/CDC strongly encourages the applicant to submit the application electronically by using the forms and instructions posted for this announcement on www.Grants.gov, the official Federal agency wide E-grant Web site. Only applicants who apply on-line are permitted to forego paper copy submission of all application forms.

Registering an organization through www.Grants.gov is the first step in submitting applications online. Registration information is located in the “Get Registered” screen of www.Grants.gov. While application submission through www.Grants.gov is optional, applicants are strongly encouraged to use this online tool.

Please visit www.grants.gov at least 30 days prior to filing an application to become familiar with the registration and submission processes. Under “Get Registered,” the one-time registration process will take three to five days to complete; however, as part of the Grants.gov registration process, registering your organization with the Central Contractor Registry (CCR) annually could take an additional one to two days to complete. HHS/CDC suggests submitting electronic applications prior to the closing date so that if difficulties are encountered, a hard copy of the application can be submitted prior to the deadline.

Paper Submission:

Application forms and instructions are available on the HHS/CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/apps_and_forms.shtm.

If access to the Internet is not available, or if there is difficulty accessing the forms on-line, contact the HHS/CDC Procurement and Grants Office Technical Information Management Section (PGO-TIM) staff at 770-488-2700 and the application forms can be mailed.

IV.2. Content and Form of Submission

Application:

A Project Abstract must be submitted with the application forms. The abstract must be submitted in the following format:

· Maximum of one page

· Font size: 12 point unreduced, Times New Roman

· Single spaced

· Paper size: 8.5 by 11 inches

· Page margin size: One inch

The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. This Abstract must not include any proprietary/confidential information.

A project narrative must be submitted with the application forms. The narrative must be submitted in the following format:

· Maximum number of pages: 25. If the narrative exceeds the page limit, only the first pages which are within the page limit will be reviewed.

· Font size: 12 point unreduced, Times New Roman

· Double spaced

· Paper size: 8.5 by 11 inches

· Page margin size: One inch

· Number all narrative pages; not to exceed the maximum number of pages.

· Printed only on one side of page.

· Held together only by rubber bands or metal clips; not bound in any other way.

The narrative should address activities to be conducted over the entire project period and must include the following items in the order listed:

1. Program Plan: In developing the application under this announcement, please review the recipient activities and, in particular, evaluation criteria and respond concisely and completely. The program plan should address activities to be conducted of the entire five-year budget period.

2. Methods

3. Personnel/Staff

4. Budget Justification

Additional information may be included in the application appendices. The appendices will not be counted toward the narrative page limit. This additional information includes:

· Curriculum Vitas

· Resumes

· Organizational Charts

· Letters of Support

Additional information submitted via Grants.gov should be labeled:

· Appendix A-Curriculum Vitas, Appendix B-Resumes, etc.

No more than 5 should be uploaded per application.

Applying agencies or organizations are required to have a Dun and Bradstreet Data Universal Numbering System (DUNS) number to apply for a grant or cooperative agreement from the Federal government. The DUNS number is a nine-digit identification number, which uniquely identifies business entities. Obtaining a DUNS number is easy and there is no charge. To obtain a DUNS number, access the Dun and Bradstreet website or call 1-866-705-5711.

Additional requirements that may require submittal of additional documentation with the application are listed in section “VI.2. Administrative and National Policy Requirements.”

IV.3. Submission Dates and Times

Application Deadline Date: July 27, 2007

Explanation of Deadlines: Applications must be received in the HHS/CDC Procurement and Grants Office by 5:00 p.m. Eastern Time on the deadline date.

Applications may be submitted electronically at www.Grants.gov. Applications completed on-line through Grants.gov are considered formally submitted when the applicant organization’s Authorizing Organization Representative (AOR) electronically submits the application to www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been submitted electronically by the applicant organization’s AOR to Grants.gov on or before the deadline date and time.

When submission of the application is done electronically through Grants.gov (http://www.grants.gov), the application will be electronically time/date stamped and a tracking number will be assigned, which will serve as receipt of submission. The AOR will receive an e-mail notice of receipt when HHS/CDC receives the application.

If submittal of the application is by the United States Postal Service or commercial delivery service, the applicant must ensure that the carrier will be able to guarantee delivery by the closing date and time. The applicant will be given the opportunity to submit documentation of the carrier’s guarantee, if HHS/CDC receives the submission after the closing date due to: (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time; or (2) significant weather delays or natural disasters. If the documentation verifies a carrier problem, HHS/CDC will consider the submission as having been received by the deadline.

If a hard copy application is submitted, HHS/CDC will not notify the applicant upon receipt of the submission. If questions arise on the receipt of the application, the applicant should first contact the carrier. If an applicant still has questions, contact the PGO-TIM staff at (770) 488-2700. The applicant should wait two to three days after the submission deadline before calling. This will allow time for submissions to be processed and logged.

This announcement is the definitive guide on application content, submission address, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline above, it will not be eligible for review. The application face page will be returned by HHS/CDC with a written explanation of the reason for non-acceptance. The applicant will be notified the application did not meet the submission requirements.

IV.4. Intergovernmental Review of Applications

The application is subject to Intergovernmental Review of Federal Programs, as governed by Executive Order (EO) 12372. This order sets up a system for state and local governmental review of proposed federal assistance applications. Contact the state single point of contact (SPOC) as early as possible to alert the SPOC to prospective applications and to receive instructions on the State’s process. Visit the following Web address to get the current SPOC list:

http://www.whitehouse.gov/omb/grants/spoc.html

IV.5. Funding Restrictions

Restrictions, which must be taken into account while writing the budget, are as follows:

· Recipients may not use funds for research.

· Recipients may not use funds for clinical care.

· Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.

· Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

· The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.

If requesting indirect costs in the budget, a copy of the indirect cost rate agreement is required. If the indirect cost rate is a provisional rate, the agreement should be less than 12 months of age.

The recommended guidance for completing a detailed justified budget can be found on the HHS/CDC Web site, at the following Internet address:

http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

Application Submission Address:

Electronic Submission:

HHS/CDC strongly encourages applicants to submit applications electronically at www.Grants.gov. The application package can be downloaded from www.Grants.gov. Applicants are able to complete it off-line, and then upload and submit the application via the Grants.gov Web site. E-mail submissions will not be accepted. If an applicant has technical difficulties in Grants.gov, customer service can be reached by E-mail at support@grants.gov or by phone at 1-800-518-4726 (1-800-518-GRANTS). The Customer Support Center is open from 7:00a.m. to 9:00p.m. Eastern Time, Monday through Friday.

HHS/CDC recommends that submittal of the application to Grants.gov should be early to resolve any unanticipated difficulties prior to the deadline. Applicants may also submit a back-up paper submission of the application. Any such paper submission must be received in accordance with the requirements for timely submission detailed in Section IV.3. of the grant announcement. The paper submission must be clearly marked: “BACK-UP FOR ELECTRONIC SUBMISSION.” The paper submission must conform to all requirements for non-electronic submissions. If both electronic and back-up paper submissions are received by the deadline, the electronic version will be considered the official submission.

The applicant must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov Web site. Use of file formats other than PDF may result in the file being unreadable.

Paper Submission:

Applicants should submit the original and two hard copies of the application by mail or express delivery service to:

Technical Information Management – PS07-764

Department of Health and Human Services

CDC Procurement and Grants Office

2920 Brandywine Road, MS E-14

Atlanta, GA 30341

V. Application Review Information

Component 1

V.1. Criteria

Applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the cooperative agreement. Measures of effectiveness must relate to the performance goals stated in the “Purpose” section of this announcement. Measures must be objective and quantitative and must measure the intended outcome. The measures of effectiveness must be submitted with the application and will be an element of evaluation.

The application will be evaluated against the following criteria:

Plan (40 Points): a succinct statement of the intent and desired outcome(s) of the project and clearly stated and measurable outcome objectives to be achieved by the projects. Is the plan adequate to carry out the proposed objectives? How complete and comprehensive is the plan for the proposed project period? Does the plan include quantitative process and outcome measures?

Methods (35 Points): clear statement of approach and activities required to achieve the stated outcome objectives for increased HIV screening. The relationship between activities and objectives must be explicitly demonstrated. Description of activities must include a delineation of resources required, identification of the personnel who will perform the work, and a management plan with description of the systems and procedures which will be used to manage the progress, timeline, budget and operations of the project. Are the proposed methods feasible? To what extent will they accomplish the program goals?

Budget and Justification (Reviewed, but not scored) The budget will be reviewed to determine the extent to which it is reasonable, clearly justified, consistent with the intended use of the funds, and allowable. All budget categories should be itemized.

Component 2

V.1. Criteria

The application will be evaluated against the following criteria:

Component 3

V.1. Criteria

The application will be evaluated against the following criteria:

Plan (40 Points): a succinct statement of the intent and desired outcome(s) of the project and clearly stated and measurable outcome objectives to be achieved by the project. Is the plan adequate to carry out the proposed objectives? How complete and comprehensive is the plan for the proposed project period? Does the plan include quantitative process and outcome measures?

Methods (35 Points): clear statement of approach and activities required to achieve the intended outcome objectives of improving the capability of individual programs to assess intended and unintended patient outcomes with increased HIV screening. The relationship between activities and objectives must be explicitly demonstrated. Description of activities must include a delineation of resources required, identification of the personnel who will perform the work, and a management plan with description of the systems and procedures which will be used to manage the progress, timeline, budget and operations of the project. Are the proposed methods feasible? To what extent will they accomplish the program goals?

Personnel (25 Points): the qualifications and experience of key personnel, other professional staff and support staff available to carry out the activities. Do the staff members have appropriate experience? Are the staff roles clearly defined? As described, will the staff be sufficient to accomplish the program goals? Is there evidence of success with past performance of similar projects for the development and dissemination of tools and models for evaluating provider behavior or patient outcomes?

V.2. Review and Selection Process

Applications will be reviewed for completeness by HHS/CDC Procurement and Grants Office (PGO) staff, and for responsiveness jointly by NCHHSTP and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet submission requirements.

An objective review panel will evaluate complete and responsive applications according to the criteria listed in the “V.1. Criteria” section above.

Applications will be funded in order by score and rank determined by the review panel. In addition, the following factors may affect the funding decision:

· Maintaining diversity of providers and health care settings served;

· Diversity of target audiences to include pregnant women (component 1), populations disproportionately affected by HIV, such as African Americans (components 1, 2 & 3).

· Preference will be given to organizations with two or more years of prior experience with: (1) the incorporation of PMTCT into health care provider education (component 1); (2) offering of universal voluntary HIV testing to pregnant women as a routine part of prenatal care (component 1); (3) the implementation of voluntary rapid HIV testing programs in health care settings (components 1& 2); (4) the development and dissemination of provider and patient educational materials on HIV suitable for use in health-care settings (components 1 & 2); and (5) development, design testing and dissemination of effective evaluation models for assessing patient outcomes and satisfaction in health-care settings (component 3).

· HHS/CDC will provide justification for any decision to fund out of rank order.

V.3. Anticipated Announcement Award Dates

Notification of awards will be sent by August 31, 2007.

VI. Award Administration Information

VI.1. Award Notices

Successfully selected applicants will receive a Notice of Award (NoA) from the HHS/CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and emailed to the program director and a hard copy mailed to the recipient fiscal officer identified in the application.

Unsuccessful applicants will receive notification of the results of the application review by mail.

VI.2. Administrative and National Policy Requirements

Successful applicants must comply with the administrative requirements outlined in 45 CFR Part 74 and Part 92, as appropriate. The following additional requirements apply to this project:

· AR-4 HIV/AIDS Confidentiality Provisions

· AR-5 HIV Program Review Panel Requirements

· AR-7 Executive Order 12372

· AR-9 Paperwork Reduction Act Requirements

· AR-10 Smoke-Free Workplace Requirements

· AR-11 Healthy People 2010

· AR-12 Lobbying Restrictions

· AR-14 Accounting System Requirements

· AR-20 Conference Support

· AR-21 Small, Minority, and Women-Owned Business

· AR-23 States and Faith-Based Organizations

· AR-24 Health Insurance Portability and Accountability Act Requirements

· AR-25 Release and Sharing of Data

· AR-27 Conference Disclaimer and Use of Logos

Additional information on the requirements can be found on the HHS/CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/Addtl_Reqmnts.htm.

For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html

VI.3. Reporting Requirements

The applicants selected for funding (recipients) when each of the 5 year budget periods is ended must provide HHS/CDC with an original and two copies of the following reports:

I. Interim Progress Report (IPR, Formerly known as Continuation Award Application) 90 days before each budget period ended. Detailed guidance letter for IPR will be sent to all awardees 120 days before each budget period ends. The required content of IPR is as follows:

a. Interim progress of project activities and objectives for the current budget year.

b. Interim financial status (progress) for estimating unobligated funds balance.

c. Proposed program (project) activities and objectives for the upcoming continuation budget year.

d. Proposed budget associated the proposed project activities for the upcoming budget year.

e. Other additional information or data as required in the report guidance letter to be sent to the recipients.

II. Annual Progress (Performance) Report within 90 days from the each budget year ended in accordance with 45CFR92.40 or 45CFR74.51.

III. Financial Status Reports (Standard Form 269) within 90 days from the each budget year ended in accordance with 45CFR92.41 or 45CFR74.52.

The reports must be mailed to the Grants Management Specialist listed in the “VII. Agency Contacts” section of this announcement.

VII. Agency Contacts

HHS/CDC encourages inquiries concerning this announcement.

For general questions, contact:

Technical Information Management Section

Department of Health and Human Services

CDC Procurement and Grants Office

2920 Brandywine Road, MS E-14

Atlanta, GA 30341

Telephone: 770-488-2700

For program technical assistance, contact:

Margaret A. Lampe, Project Officer

Department of Health and Human Services

1600 Clifton Road, Mail Stop E-45

Atlanta, GA 30333

Telephone: 404-639-5189

E-mail: mlampe@cdc.gov

For financial, grants management, or budget assistance, contact:

Kang Lee, Grants Management Specialist

Department of Health and Human Services

CDC Procurement and Grants Office

2920 Brandywine Road, Mail stop: E-14

Atlanta, GA 30341

Telephone: 404-639-5357

E-mail: kil8@cdc.gov

HHS/CDC Telecommunications for the hearing impaired or disabled is available at: TTY 770-488-2783.

VIII. Other Information

Other HHS/CDC funding opportunity announcements can be found on the HHS/CDC Web site, Internet address: http://www.cdc.gov/od/pgo/funding/FOAs.htm.

HHS/CDC’s Revised Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in Health Care Settings can be found on the CDC Web site, http://www.cdc.gov/hiv/topics/testing/healthcare.

CDC Home Page: http://www.cdc.gov

CDC Funding Web Page: http://www.cdc.gov/od/pgo/funding/FOAs.htm

CDC Forms Web Page: